Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|June 5, 2024
Does Improving Depression Symptoms in Young Adults With Inflammatory Bowel Disease Alter Their Microbiome?Julie M Davies, Jing Jie Teh, Tatjana Ewais, et al.
Genetics|February 5, 2008
DAF-16-dependent suppression of immunity during reproduction in Caenorhabditis elegansSachiko Miyata, Jakob Begun, Emily R Troemel, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 8, 2026
Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging TherapeuticsYoon-Kyo An, Robert Gilmore, Graham Radford-Smith, et al.
Infection and Immunity|March 26, 2003
Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesisCosti D Sifri, Jakob Begun, Frederick M Ausubel, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Comprehensive systematic review and pooled analysis of real-world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatmentEmi Khoo, Andrew Lee, Teresa Neeman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 12, 2023
Cannabidiol - Help and hype in targeting mucosal diseasesMd Moniruzzaman, Taskeen Iqbal Janjua, Jennifer H Martin, et al.
Journal of Crohn'S & Colitis|July 9, 2023
Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative ColitisRobert Gilmore, Wei Lian Tan, Richard Fernandes, et al.
Intestinal Research|June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's diseaseRobert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
Gut Microbes|October 5, 2017
Colonic thioguanine pro-drug: Investigation of microbiome and novel host metabolismTimothy Florin, Ramya Movva, Jakob Begun, et al.
Pageof 10